IVD

Orion Sheds Diagnostic Unit for $200M Plus Milestones

Orion Diagnostica develops Point-of-Care tests and earned about $67 million in sales for its most recent reported year.

Companion Diagnostics Space Warms Up with Collaboration

Bristol-Myers Squibb has teamed up with Illumina to develop companion diagnostics for oncology immunotherapies.

Qiagen To Unveil 2 Liquid Biopsy Tests at AACR

Qiagen has developed liquid biopsy panels for prostate and lung cancer and is set to introduce the products at the American Association for Cancer Research annual meeting this week.

Who Needs Needles? Not These Medtech Companies

These seven medtech companies aren't just moving the needle, they're getting rid of it all together!

Fresh Off IPO, Quanterix Meets Its DestiNA

Quanterix teams up with DestiNA to develop assays to detect liver toxicity in patients.

This Liquid Biopsy Can Rule Out Early-Stage Lung Cancer

A new study has confirmed the accuracy of the Xpresys Lung 2 test developed by Integrated Diagnostics.

In a First, Qiagen Turns Focus to Prenatal Testing

Qiagen, known for its oncology offerings, is set to develop assays for the non-invasive prenatal testing market through a $40 million collaboration with Natera.

SQI Test Detects Heart Attack Before It Happens

SQI Diagnostics and Predictive Health bring cardiovascular diagnostics to the forefront with the launch of a serum-based heart attack probability test.

DOD-Backed MeMed Feels the Need for Speed

The company says its ImmunoPoC platform can determine in 15 minutes whether a patient has a bacterial or viral infection.

VC Firms Still Find Liquid Biopsy Sexy

A $45 million funding round completed by DiaCarta to help develop a liquid biopsy test for colorectal cancer is just the latest proof that venture capitalists continue to see liquid biopsy companies as an attractive investment.

Early Detection of HIV May Be as Easy as Spitting

Stanford researchers aim to simplify HIV testing and boost early detection rates through a saliva-based test.

How a New Test Could Solve a Costly Problem

A molecular diagnostics company wants to expand its new cartridge-based platform to help orthopedic surgeons make more informed care decisions for patients with a potential joint infection.

The Biomarker Disruptor

Would you rather get a biopsy or a blood test to check for prostate cancer?

What Products Will Ultimately Win in Diagnostics?

Panelists at the recent J.P. Morgan Healthcare Conference in San Francisco, CA were charged with separating the hype from the reality in the field of diagnostics and offered insight into what products will win in the space.